Lenalidomide
≥98% (HPLC), powder, cereblon binder
Manufacturer: Sigma Aldrich
CAS Number: 191732-72-6
Synonym(S): Lenalidomide, 1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole, 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, 3-(4-Amino-1-oxoisoindolin-2-yl)piperidin-2,6-dione, 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione, CC 5013, CC-5013
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | SML2283-100-MG | In Stock | ₹ 6,559.95 |
| 250 MG | SML2283-250-MG | In Stock | ₹ 14,732.83 |
SML2283 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 6,559.95
GST (18%): ₹ 1,180.791
Total Price: ₹ 7,740.741
product name
Lenalidomide, ≥98% (HPLC)
ligand
lenalidomide
Assay
≥98% (HPLC)
form
powder
reaction suitability
reagent type: ligand
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C1N(C2CCC(NC2=O)=O)CC3=C1C=CC=C3N
InChI
1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
Other Options
Related Products
Description
- Biochem/physiol Actions: Lenalidomide, a derivative of thalidomide, is an immunomodulatory agent that is approved drug for treatment of multiple myeloma. Apparently Lenalidomide is a ligand of ubiquitin E3 ligase cereblon that induces the enzyme to degrade the Ikaros transcription factors IKAROS family zinc finger 1 (IKZF1) and IKZF3. Lenalidomide possess pleiotropic antitumor effects.[1] It is used in the treatment of 5q-deletion associated myelodysplastic syndrome (del(5q)-MDS).[2]
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Repr. 1B - STOT RE 2
Target Organs
Blood
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
product name: Lenalidomide, ≥98% (HPLC)
ligand: lenalidomide
Assay: ≥98% (HPLC)
form: powder
reaction suitability: reagent type: ligand
color: white to beige
solubility: DMSO: 2 mg/mL, clear
storage temp.: 2-8°C
SMILES string: O=C1N(C2CCC(NC2=O)=O)CC3=C1C=CC=C3N
InChI: 1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
product name: __
ligand: __
Assay: ≥98% (HPLC)
form: powder
reaction suitability: __
color: white to beige
solubility: DMSO: 2 mg/mL, clear
storage temp.: −20°C
SMILES string: O=C1C[C@H](C)N(C(N2CC(C3)C3C2)=O)C4=CC=C(C(NCCC5CC5)=O)C=C4N1
InChI: __
product name: __
ligand: __
Assay: ≥98% (HPLC)
form: powder
reaction suitability: __
color: white to beige
solubility: DMSO: 2 mg/mL, clear
storage temp.: 2-8°C
SMILES string: ClC(C=C1)=CC=C1C2=CC(CNCCCCSC[C@H]3O[C@@H](N(C=N4)C5=C4C(N)=NC=N5)[C@H](O)[C@@H]3O)=CC=C2
InChI: __
